The BARDA Accelerator Network Hub for Medical Devices and Diagnostics
Are you working on groundbreaking diagnostics or medical device countermeasures that address public health? I-CREATE is part of a global network of accelerator hubs that provide product development funding, accelerator services, and access to expertise for innovators developing health security solutions.
Startups and university-backed projects worldwide can apply for non-dilutive funding ranging from $50K to $200K. This funding supports the development, evaluation, or validation of innovative solutions aligned with BARDA’s mission to enhance pandemic preparedness and health security. I-CREATE supports the development and acceleration of novel diagnostics and medical devices to detect, prevent, or respond to medical consequences that result from health security threats.
Focus areas of interest include new and novel approaches for the detection and diagnosis of pathogens and consequences of biological threats in BARDA’s mission space. Examples of technologies we’re excited to fund:
Pathogen agnostic approaches
Lab at home
Rapid and accurate tests
Low-cost tests
Simple and user-friendly sampling approaches (i.e. breath)
More equitable and accessible innovations
Applications for the first cohort are closed. However, the application link is still open for consideration for the next cohort in early 2025.
Selected applicants will be invited to submit full proposals, including milestones and budgets by October 14, 2024
The first round of Awards will be announced by the end of December 2024.
Funding and program services begin in January 2025.
Applications for the first cohort are closed. However, the application link is still open for consideration for the next cohort in early 2025.
I-CREATE provides non-dilutive funding, through milestone-based awards from $50K to $200K, over the 6-month program period. Funds may be used for proof-of-concept and reaching other value inflection points.
- Pathogen agnostic approaches
- Lab at home
- Rapid and accurate tests
- Low-cost tests
- Simple and user-friendly sampling approaches (e.g. breath)
- More equitable and accessible innovations
I-CREATE supports health security innovators, startups, and portfolio companies by providing wraparound accelerator services including entrepreneurship education and access to technical and business/commercialization expertise and resources.
Selected companies will receive 1:1 support from subject matter experts in areas of regulatory, quality, clinical, commercialization, and fundraising while leveraging a vast network of investors, development partners, and verification and validation service providers.
Selected companies have the option to access University Lab Partner's $3M+ state-of-the-art scientific equipment and infrastructure to facilitate technology development, validation, and commercialization.
Additional funding & support opportunity coming soon!
The top contestant will win a grand prize of $50K. Five runners-up will receive an incredible package including tailored mentoring for success and access to our extensive network of mentors, collaborative learning, networking opportunities, and educational programming designed specifically for early-stage companies.
Diagnostics and Medical Device platforms technologies aligned with BARDA’s mission to enhance pandemic preparedness and health security.
Seeking applicants from all over the world!
Foreign Owned Influence: the Awardee shall not have, and shall ensure that affiliates, Sub-awardees and DEV Project Sub-awardees do not have foreign investment capital/interests from USG prohibited sources list of embargoed and sanctioned countries, as defined by U.S. Departments of Treasury and Commerce.
I-CREATE is seeking proposals for the development of innovative diagnostic and medical device innovations, in alignment with BARDA’s mission to promote health security. Innovators are invited to submit proposals for funding to allow:
Submit your applications by August 23 to be considered for the first cohort of I-CREATE. Applications will remain open for future cohorts.
To view a Word Document of the application click here.
First Cohort Timeline